Plus Therapeutics
Earnings Date & Report
Last updated:
Plus Therapeutics’s last earnings date was on 18 Apr 2024.
Plus Therapeutics stock Earnings report, Estimates & History
| 2019-11-14 | -5.85 | -0.03 |
|---|---|---|
| 2020-03-30 | -0.66 | 0.23 |
| 2020-05-14 | -0.75 | -0.28 |
| 2020-08-10 | -0.75 | -0.26 |
| 2020-10-22 | -0.55 | -0.39 |
| 2021-02-22 | -0.39 | -0.67 |
| 2021-04-22 | -0.34 | -0.33 |
| 2021-07-22 | -0.24 | -0.25 |
| 2021-10-21 | -0.24 | -0.28 |
| 2022-02-24 | -0.27 | -0.27 |
| 2022-04-21 | -0.18 | -0.19 |
| 2022-07-21 | -0.22 | -0.24 |
| 2022-10-20 | -0.2 | -0.19 |
| 2022-12-31 | -0.14315 | -0.21878 |
| 2023-02-23 | -0.12 | -0.22 |
| 2023-04-20 | -0.13 | -0.14 |
| 2023-08-03 | -1.91 | -53.95 |
Estimated - a value of Apple’s earnings per share estimated by analysts based on its past and current financial statements.
Reported - a real value of Apple’s earnings per share reported by the company.
Plus Therapeutics stock earnings history by quarter
| Date | Estimated EPS | Reported EPS | Estimated revenue | Actual revenue | Earnings call | |
|---|---|---|---|---|---|---|
| 18 Apr 2024 | N/A | N/A | N/A | N/A | N/A | |
| 21 Feb 2024 | N/A | N/A | N/A | N/A | N/A | |
| 18 Oct 2023 | N/A | -$1.91 | N/A | 790K | N/A | |
| 3 Aug 2023 | Missed | -$1.91 | -$53.95 | 790K | N/A | |
| 20 Apr 2023 | Missed | -$0.13 | -$0.14 | 740K | N/A | Earnings Call Transcript |
| 23 Feb 2023 | Missed | -$0.12 | -$0.22 | 1.27M | 224K | Earnings Call Transcript |
| 31 Dec 2022 | Missed | -$0.14 | -$0.22 | 256.25K | 224K | |
| 20 Oct 2022 | Beat | -$0.2 | -$0.19 | N/A | N/A | Earnings Call Transcript |
| 21 Jul 2022 | Missed | -$0.22 | -$0.24 | N/A | N/A | Earnings Call Transcript |
| 21 Apr 2022 | Missed | -$0.18 | -$0.19 | N/A | N/A | |
| 24 Feb 2022 | Matched | -$0.27 | -$0.27 | N/A | N/A | Earnings Call Transcript |
| 21 Oct 2021 | Missed | -$0.24 | -$0.28 | N/A | N/A | Earnings Call Transcript |
| 22 Jul 2021 | Missed | -$0.24 | -$0.25 | N/A | N/A | Earnings Call Transcript |
| 22 Apr 2021 | Beat | -$0.34 | -$0.33 | N/A | N/A | Earnings Call Transcript |
| 22 Feb 2021 | Missed | -$0.39 | -$0.67 | N/A | N/A | Earnings Call Transcript |
| 22 Oct 2020 | Beat | -$0.55 | -$0.39 | 3.21M | N/A | |
| 10 Aug 2020 | Beat | -$0.75 | -$0.26 | 308.33K | 185K | Earnings Call Transcript |
| 14 May 2020 | Beat | -$0.75 | -$0.28 | 316.07K | 118K | Earnings Call Transcript |
| 30 Mar 2020 | Beat | -$0.66 | $0.23 | 3.40M | 1.18M | Earnings Call Transcript |
| 14 Nov 2019 | Beat | -$5.85 | -$0.03 | 930.34M | 4.77M | Earnings Call Transcript |
Plus Therapeutics Earnings report FAQs
When is Plus Therapeutics's next Earnings date?
The company has not set the next earnings date yet. The latest Plus Therapeutics's earnings date was on 20 Apr 2023.
What are earnings?
Earnings are the net income of a company after all taxes and expenses have been deducted. They are the main figure for determining the price of a company's shares.
What does EPS stand for?
EPS stands for earnings per share, which is the basic measure of a company's earnings. It indicates how much money each share earned for the company.
How to calculate earnings per share?
Earnings per share (EPS) can be calculated by dividing a company's net income by the number of common shares outstanding. If the company pays preferred dividends, they are first subtracted from the company’s net income.
Formula:
What is earnings per share estimate?
Earnings estimate is analysts’ prediction of a company’s earnings value in the next quarter or fiscal year based on past and current financial statements of a company. It is an important indicator for both current and future investors.